Pfizer and Wyeth Reach Buy-Out Deal

Monday, January 26, 2009

Drugmakers Pfizer and Wyeth reached a $68 billion buy-out deal today.

Pfizer will acquire Wyeth, paying about 50 dollars a share, according to early reports in the New York Times and Wall Street Journal.

The deal will help Pfizer cushion itself against a steep revenue decline expected over the next several years as Lipitor, the world's best-selling drug, and other major products lost patent protection.


More in:

Leave a Comment

Email addresses are required but never displayed.

Get the WNYC Morning Brief in your inbox.
We'll send you our top 5 stories every day, plus breaking news and weather.


Latest Newscast




WNYC is supported by the Charles H. Revson Foundation: Because a great city needs an informed and engaged public


Supported by